Navigation Links
Southern Research Wins $37 Million Black & Veatch Sub-Contract for Biological Threat Reduction Program
Date:12/2/2008

BIRMINGHAM, Ala., Dec. 2/PRNewswire-USNewswire/ --Southern Research Institute -- a not-for-profit scientific organization that conducts basic and applied research in the areas of preclinical drug discovery and development, advanced engineering, environmental and energy production -- today announced that it has been awarded a subcontract from Black & Veatch to help support the U.S. Department of Defense's Biological Threat Reduction Program (BTRP) in the Ukraine.

The award is expected to generate up to $37 million in revenues for Southern Research over the next five years. "We are honored that Black & Veatch has selected our Southern Research team to provide support for such an important global program," said John A. "Jack" Secrist III, Ph.D., president and CEO of Southern Research Institute. "Working with Black & Veatch on the Ukraine task order will allow Southern Research to not only contribute to the safety and well-being of the United States, but to use our knowledge and expertise for global safety as well."

As the prime integrating contractor, Black & Veatch will design, engineer and deploy systems, processes and technologies to further strengthen reporting, detection and response capabilities. Southern Research will provide a wide range of scientific consulting in the design and implementation of modern diagnostic laboratories throughout the Ukraine. Additionally, Southern Research will facilitate collaborative research projects conducted by US-Ukraine interdisciplinary teams. The Southern Research biological threat reduction program will be managed by Mary Guttieri, Ph.D., based in Washington DC, in conjunction with William Severson, Ph.D., and Colleen B. Jonsson, Ph.D., based in Birmingham, Ala.

The Defense Threat Reduction Agency (DTRA), the BTRP's implementer, awarded Black & Veatch, a leading global engineering consulting and construction company, one of th
'/>"/>

SOURCE Southern Research Institute
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. USAID Assistant Administrator Hess Travels to Southern Africa
3. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
4. MIT Holding, Inc. signs partnership agreement with Georgia Southern University
5. Angel Flight West Recognizes Southern California Pilots at 24th Anniversary
6. Southern California Wildfires Continue to Threaten Residential Areas
7. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
8. VA Remains Open for Care for Southern California Vets
9. Red Cross Receives $250,000 From Wal-Mart to Assist With Southern California Wildfire Relief Efforts
10. The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires
11. CNA/NNOC Nurse Volunteers Deployed to Southern California Firestorm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 General Data Company Inc., ... tracking and data management products and solutions, has ... Inc., (TBS) of Durham, North Carolina, a leading ... for the clinical and research pathology marketplace. TBS ... which provides specialty products and solutions to hospitals, ...
(Date:5/24/2013)... the first conference of its kind, Impacts World ... and decision makers from politics, business and civil ... integrated climate impact research across sectors and scales. ... World 2013 on May 27th, 1pm to 1:55pm ... , Speakers include: , Connie Hedegaard, ...
(Date:5/24/2013)... Finding the answer for this is at the centre of ... the Bergen fMRI Group at the University of Bergen (UiB) ... The way they do this is by studying people who ... mental illness. For a five-year period, the group is studying ... report published in Frontiers in Human Neuroscience shows ...
(Date:5/24/2013)... May 24, 2013 The Icahn School ... International (CDI) exclusive license rights to commercially develop ... medicine applications. These cells are capable of further differentiation ... cardiomyocytes, endothelial cells, and vascular smooth muscle cells, and ... damaged heart tissue. , The original agreement announced in ...
(Date:5/24/2013)... The creative flair and design talent of ... Institute of Textiles and Clothing (ITC) have won applause ... held on 22 May at The Mira Hong Kong. ... design students, various knitwear producers and yarn suppliers, the ... four outfits from 20 graduating students majoring in knitwear ...
Breaking Medicine News(10 mins):Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:PolyU Stages Knitwear Fashion Show 2
... rankings aim to help families choose best option , , ... Medicare and Medicaid Services unveiled an updated Web site ... for elderly Americans and their families. , The updated ... similar to that used for hotels and motels, to ...
... NY, December 18, 2008Medical acupuncture, which is acupuncture performed ... school, is being used increasingly for pain control. Richard ... , a peer-reviewed journal ( www.liebertpub.com/acu ) and the ... is at the forefront of these efforts in the ...
... the European Association of Urology (EAU) will be held from ... (SE). The scientific programme covers the whole range of the ... it will all be discussed at the congress. ... are extended to a full-day event called EAU International Day ...
... study,s design may be to blame for desmoteplase,s poor showing, ... experimental clot-busting drug derived from the saliva of the vampire ... trial. , But hope for the drug, called desmoteplase, remains ... large enough to provide clear results. , "The sample size ...
... who suffer from thinning hair and hair loss with an all-natural ... all-natural DHT blockers with no side effects. , ... ... offering patients who suffer from thinning hair and hair loss with ...
... drug eluting stents (DES) stents coated with medication to ... angioplasty had better outcomes one year later than patients with ... published in CMAJ http://www.cmaj.ca/press/080050.pdf . , Mortality ... stents was significantly lower than for those with bare metal ...
Cached Medicine News:Health News:Government Launches Nursing Home Rating System 2Health News:Government Launches Nursing Home Rating System 3Health News:Annual Congress European Association of Urology: highlights in Stockholm 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 3Health News:Your Chemist Shop Offers Patients a Revolutionary Alternative to Other Hair Loss Treatments for Both Men and Women 2
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. (OTC ... medical device company that develops and sells high performance ... its rights offering.  In addition, the concurrent temporary reduction ... expired on May 17, 2013. Nephros estimates ... from the rights offering.   A portion of the proceeds ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... SILVER SPRING, Md., May 9, 2011 /PRNewswire-USNewswire/ – CoMeD ... a Republican State Senator filed an amendment to regulate ... made it illegal to buy, sell, manufacture, deliver, import, ... 0.3 micrograms of organic or inorganic mercury per milliliter ...
... May 9, 2011 TriReme Medical, Inc. (TriReme), a ... treatment of complex vascular disease, announced today the appointment ... their Board of Directors. Mr. Bose, Founder ... Singapore and was until recently Company Group Chairman at ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members 2
The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....
The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...
... SmartDriver System consists of a pistol-grip handpiece ... with a wide range of couplers that ... orthopedic surgical applications., ,The Battery SmartDriver ... compared to the original Battery SmartDriver. The ...
... Meniscus Implant (CMI) is a type I ... irreparable meniscus tear or loss of meniscus ... procedure. The purpose of the CMI ... and return to a more vigorous lifestyle, ...
Medicine Products: